Nikola Trbovic

SV Health Investors is a boston-based venture capital firm focused on investments in biotechnology and healthcare industry.

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

Raised $207,000,000.00 from AbbVie, Avalon Ventures, Bain Capital Life Sciences, RA Capital Management, Polaris Partners, Pfizer Venture Investments and Versant Ventures.

Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.

Raised $113,000,000.00 from WuXi AppTec, venBio Partners, OUP (Osage University Partners), Alexandria Venture Investments, Henri Termeer, Omega Funds, Advent Life Sciences, Nextech Invest, Canaan Partners and Celgene.

Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer.

Raised $147,600,000.00 from Takeda Ventures, Pfizer Venture Investments, Matrix Capital Management, Vertex Ventures HC, AbbVie, Surveyor Capital and SR One.

Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.

Raised $32,000,000,000.00 from Starboard Value.

Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.

Raised $637,000,000.00 from Biotechnology Value Fund, RA Capital Management, Gates Frontier Fund, SR One, Pfizer Venture Investments, Bain Capital Life Sciences, Atlas Venture, Google Ventures, SV Health Investors and Lightstone Ventures.